Tianda Pharmaceuticals Limited (HKG:0455)
0.1040
0.00 (0.00%)
Jul 30, 2026, 11:15 AM HKT
Tianda Pharmaceuticals Market Cap
Tianda Pharmaceuticals has a market cap or net worth of 223.6 million as of July 31, 2026. Its market cap has decreased by -40.57% in one year.
Market Cap
223.60M
Enterprise Value
284.57M
Revenue
322.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since October 27, 1993, Tianda Pharmaceuticals's market cap has decreased from 315.36M to 223.60M, a decrease of -29.10%. That is a compound annual growth rate of -1.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 223.60M | -19.38% |
| Dec 31, 2025 | 277.36M | -23.67% |
| Dec 31, 2024 | 363.36M | -22.48% |
| Dec 29, 2023 | 468.71M | -46.17% |
| Dec 30, 2022 | 870.77M | 26.56% |
| Dec 31, 2021 | 688.01M | 131.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 630.05M |
| Zhongzhi Pharmaceutical Holdings | 604.52M |
| Wai Yuen Tong Medicine Holdings | 356.60M |
| China NT Pharma Group Company | 355.87M |
| Regent Pacific Group | 268.47M |
| Extrawell Pharmaceutical Holdings | 217.50M |
| Shenzhen Neptunus Interlong Bio-technique Company | 179.55M |
| Kontafarma China Holdings | 167.66M |